Cell tolerability and biodistribution in mice of indocyanine green-loaded lipid nanoparticles

Journal of Biomedical Nanotechnology

Volumn 8, Issue 4, 2012, Pages 594-604

  Navarro, Fabrice P ^a   Mittler, Fréd́erique ^a   Berger, Michel ^a   Josserand, Véronique ^b,c   Gravier, Julien ^a   Vinet, Françoise ^a   Texier, Isabelle ^a  

^a CEA GRENOBLE   (France)

^b INSTITUT ALBERT BONNIOT   (France)

^c UNIV GRENOBLE ALPES   (France)

Author keywords

Biodistribution; Cytotoxicity; Fluorescence imaging; Hemocompatibility; Indocyanine green; Lipid nanoparticles; Pharmacokinetics

Indexed keywords

BIODISTRIBUTIONS; FLUORESCENCE IMAGING; HEMOCOMPATIBILITY; INDOCYANINE GREEN; LIPID NANOPARTICLES;

CELL CULTURE; CYTOTOXICITY; DYES; FLUORESCENCE; MAMMALS; PHARMACOKINETICS;

NANOPARTICLES;

INDOCYANINE GREEN; LIPID NANOPARTICLE; NANOPARTICLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOFLUORESCENCE; BIOCOMPATIBILITY; BIOLOGICAL ACTIVITY; BIOLOGICAL MONITORING; BLOOD SAMPLING; CELL VIABILITY; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; EX VIVO STUDY; FEMALE; FIBROBLAST; FLUORESCENCE ANALYSIS; FLUORESCENCE IMAGING; HEMOLYSIS; HUMAN; HYDRODYNAMICS; INTESTINE ABSORPTION; MOUSE; NANOENCAPSULATION; NANOPROBE; NONHUMAN; PARTICLE SIZE; PLASMA CLEARANCE; QUANTITATIVE ANALYSIS; QUANTUM YIELD; ULTRAVIOLET SPECTROSCOPY; ZETA POTENTIAL;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; ERYTHROCYTES; FEMALE; FLUORESCENCE; HEMOLYSIS; HUMANS; INDOCYANINE GREEN; LIPIDS; MICE; MICE, NUDE; NANOPARTICLES; NIH 3T3 CELLS; TISSUE DISTRIBUTION;

EID: 84861486452     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2012.1422     Document Type: Article

References (59)

1. R. Bawa, Patents and nanomedicine. Nanomed. 2, 351 (2007).
2. W. E. Bawarski, E. Chidlowsky, D. J. Bharali, and S. A. Mousa, Emerging nanopharmaceuticals. Nanomed.-Nanotechno. Biol. Med. 4, 273 (2008).
3. Y. Y. Liu, H. Miyoshi, and M. Nakamura, Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int. J. Cancer 120, 2527 (2007).
4. D. Peer, J. M. Karp, S. Hong, O. C. FaroKHzad, R. Margalit, and R. Langer, Nanocarriers as an emerging platform for cancer therapy. Nature Nanotechnol. 2, 751 (2007).
5. N. Sanvicens and M. P. Marco, Multifunctional nanoparticles - properties and prospects for their use in human medicine. Trends Biotechnol. 26, 425 (2008).
6. E. Boisselier and D. Astruc, Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem. Soc. Rev. 38, 1759 (2009).
7. J. Cheon, Y. W. Jun, and J. T. Jang, Nanocrystals and their biomedical applications. Bull. Korean Chem. Soc. 27, 961 (2006).
8. M. Q. Zhang and C. Fang, Multifunctional magnetic nanoparticles for medical imaging applications. J. Mater. Chem. 19, 6258 (2009).
9. P. D. Marcato and N. Duran, New aspects of nanopharmaceutical delivery systems. J. Nanosci. Nanotechnol. 8, 2216 (2008).
10. R. Tong, D. A. Christian, L. Tang, H. Cabral, J. R. Baker, K. Kataoka, D. E. Discher, and J. J. Cheng, Nanopolymeric therapeutics. MRS Bull. 34, 422 (2009).
11. T. Anchordoquy and L. Xu, Drug delivery trends in clinical trials and translational medicine: Challenges and opportunities in the delivery of nucleic acid-based therapeutics. J. Pharm. Sci. 100, 38 (2011).
12. A. M. Seifalian, Y. Malam, and M. Loizidou, Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol. Sci. 30, 592 (2009).
13. S. Sofou and A. M. Alaouie, Liposomes with triggered content release for cancer therapy. J. Biomed. Nanotechnol. 4, 234 (2008).
14. J. P. Benoit, N. Anton, and P. Saulnier, Design and production of nanoparticles formulated from nano-emulsion templates - A review. J. Control. Release 128, 185 (2008).
15. M. D. Joshi and R. H. Muller, Lipid nanoparticles for parenteral delivery of actives. J. Pharm. Biopharm. 71, 161 (2009).
16. C. Passirani, N. T. Huynh, P. Saulnier, and J. P. Benoit, Lipid nanocapsules: A new platform for nanomedicine. Int. J. Pharm. 379, 201 (2009).
17. E. L. Kaijzel, G. van der Pluijm, and C. W. G. M. Lowik, Wholebody optical Imaging in animal models to assess cancer development and progression. Clin. Cancer Res. 13, 3490 (2007).
18. K. Licha and C. Olbrich, Optical imaging in drug discovery and diagnostic applications. Adv. Drug Deliv. Rev. 57, 1087 (2005).
19. M. C. Pierce, D. J. Javier, and R. Richards-Kortum, Optical contrast agents and imaging systems for detection and diagnosis of cancer. Int. J. Cancer 123, 1979 (2008).
20. R. Weissleder and M. J. Pittet, Imaging in the era of molecular oncology. Nature 452, 580 (2008).
21. J. V. Frangioni, In vivo near-infrared fluorescence imaging. Curr. Opinion Chem. Biol. 7, 626 (2003).
22. J. V. Frangioni, New technologies for human cancer imaging. J. Clin. Oncol. 26, 4012 (2008).
23. J. V. Frangioni, S. Gioux, and H. S. Choi, Image-Guided Surgery Using Invisible Near-Infrared Light: Fundamentals of Clinical Translation. Mol. Imaging 9, 237 (2010).
24. M. L. J. Landsman, G. Kwant, G. A. Mook, and W. G. Zijlstra, Light-Absorbing Properties, Stability, and Spectral Stabilization of Indocyanine Green. J. App. Physiol. 40, 575 (1976).
25. S. Mordon, J. M. Devoisselle, S. Soulie-Begu, and T. Desmettre, Indocyanine green: Physicochemical factors affecting its fluorescence in vivo. Microvascular Res. 55, 146 (1998).
26. V. Saxena, M. Sadoqi, and J. Shao, Degradation kinetics of indocyanine green in aqueous solution. J. Pharm. Sci. 92, 2090 (2003).
27. T. Desmettre, J. M. Devoisselle, and S. Mordon, Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography. Survey Ophthalmol. 45, 15 (2000).
28. T. Desmettre, S. Mordon, S. Soulie, J. M. Devoisselle, and J. M. Weisslinger, Shift of the fluorescence peak of indocyanine green (ICG) after injection: In vivo study on a vascular model. Visual Sci. 37, 5174 (1996).
29. H. M. E. Azzazy, M. M. H. Mansour, and S. C. Kazinierczak, From diagnostics to therapy: Prospects of quantum dots. Clin. Biochem. 40, 917 (2007).
30. W. B. Cai, A. R. Hsu, Z. B. Li, and X. Y. Chen, Are quantum dots ready for in vivo imaging in human subjects?. Nanoscale Res. Lett. 2, 265 (2007).
31. W. J. Parak, C. Kirchner, T. Liedl, S. Kudera, T. Pellegrino, A. M. Javier, H. E. Gaub, S. Stolzle, and N. Fertig, Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. Nano Lett. 5, 331 (2005).
32. V. Saxena, M. Sadoqi, and J. Shao, Indocyanine green-loaded biodegradable nanoparticles: Preparation, physicochemical characterization and in vitro release. Int. J. Pharm. 278, 293 (2004).
33. V. Saxena, M. Sadoqi, and J. Shao, Polymeric nanoparticulate delivery system for Indocyanine green: Biodistribution in healthy mice. Int. J. Pharm. 308, 200 (2006).
34. K. Mader, A. K. Kirchherr, and A. Briel, Stabilization of indocyanine green by encapsulation within micellar Systems. Mol. Pharm. 6, 480 (2009).
35. S. H. Pun, T. H. Kim, Y. P. Chen, C. W. Mount, W. R. Gombotz, and X. D. Li, Evaluation of temperature-sensitive, indocyanine green-encapsulating micelles for noninvasive near-infrared tumor imaging. Pharma. Res. 27, 1900 (2010).
36. V. B. Rodriguez, S. M. Henry, A. S. Hoffman, P. S. Stayton, X. D. Li, and S. H. Pun, Encapsulation and stabilization of indocyanine green within poly(styrene-alt-maleic anhydride) block-poly(styrene) micelles for near-infrared imaging. J. Biomed. Opt. 13, 1 (2008).
37. E. I. Altinoglu, T. J. Russin, J. M. Kaiser, B. M. Barth, P. C. Eklund, M. Kester, and J. H. Adair, Near-infrared emitting fluorophore-doped calcium phosphate nanoparticles for in vivo imaging of human breast cancer. acs nano 2, 2075 (2008).
38. L. W. Lo, J. S. Souris, C. H. Lee, S. H. Cheng, C. T. Chen, C. S. Yang, J. A. A. Ho, and C. Y. Mou, Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. Biomater. 31, 5564 (2010).
39. M. Detmar, S. T. Proulx, P. Luciani, S. Derzsi, M. Rinderknecht, V. Mumprecht, and J. C. Leroux, Quantitative imaging of lymphatic function with liposomal indocyanine green. Cancer Res. 70, 7053 (2010).
40. V. Saxena, M. Sadoqi, and J. Shao, Enhanced photo-stability, thermal-stability and aqueous-stability of indocyanine green in polymeric nanoparticulate systems. J. Photochem. Photobiol. B-Biol. 74, 29 (2004).
41. T. Delmas, A. C. Couffin, P. A. Bayle, F. de Crecy, E. Neumann, F. Vinet, M. Bardet, J. Bibette, and I. Texier, Preparation and characterization of highly stable lipid nanoparticles with amorphous core of tuneable viscosity. J. Colloid Interf. Sci. 360, 471 (2011).
42. T. Delmas, H. Piraux, A. C. Couffin, I. Texier, F. Vinet, P. Poulin, M. E. Cates, and J. Bibette, How to prepare and stabilize very small nanoemulsions. Langmuir 27, 1683 (2011).
43. M. Hamidi, A. Azadi, and P. Rafiei, Pharmacokinetic consequences of pegylation. Drug Deliv. 13, 399 (2006).
44. F. P. Navarro, M. Berger, S. Guillermet, V. Josserand, L. Guyon, E. Neumann, F. Vinet, and I. Texier, Lipid nanoparticle vectorization of IndoCyanine Green improves fluorescence imaging for tumor diagnosis and lymph node resection. J. Biomed. Nanotechnol. submitted.
45. I. Texier, M. Goutayer, A. Da Silva, L. Guyon, N. Djaker, V. Josserand, E. Neumann, J. Bibette, and F. Vinet, Cyanine-loaded lipid nanoparticles for improved in vivo fluorescence imaging. J. Biomed. Opt. 14, 054005 (2009).
46. M. A. Yaseen, J. Yu, B. S. Jung, M. S. Wong, and B. Anvari, Biodistribution of encapsulated indocyanine green in healthy mice. Mol. Pharm. 6, 1321 (2009).
47. J. V. Frangioni, H. S. Choi, W. Liu, P. Misra, E. Tanaka, J. P. Zimmer, B. I. Ipe, and M. G. Bawendi, Renal clearance of quantum dots. Nature Biotechnol. 25, 1165 (2007).
48. R. H. Muller, D. Ruhl, S. Runge, K. SchulzeForster, and W. Mehnert, Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant. Pharm. Res. 14, 458 (1997).
49. C. C. Muller-Goymann and M. A. Schubert, Characterisation of surface-modified solid lipid nanoparticles (SLN): Influence of lecithin and nonionic emulsifier. Eur. J. Pharm. Biopharm. 61, 77 (2005).
50. H. Yuan, F. Q. Hu, Y. Zhang, and Y. Z. Du, Nimodipine loaded lipid nanospheres prepared by solvent diffusion method in a drug saturated aqueous system. Int. J. Pharm. 348, 146 (2008).
51. A. V. Heydenreich, R. Westmeier, N. Pedersen, H. S. Poulsen, and H. G. Kristensen, Preparation and purification of cationic solid lipid nanospheres - effects on particle size, physical stability and cell toxicity. Int. J. Pharm. 254, 83 (2003).
52. M. J. Lawrence, Surfactant systems - their use in drug-delivery. Chem. Soc. Rev. 23, 417 (1994).
53. M. J. Lawrence, Surfactant systems - microemulsions and vesicles as vehicles for drug-delivery. Eur. J. Drug Metabolism Pharm. 19, 257 (1994).
54. P. E. G. Thoren, O. Soderman, S. Engstrom, and C. von Corswant, Interactions of novel, nonhemolytic surfactants with phospholipid vesicles. Langmuir 23, 6956 (2007).
55. R. C. Benson and H. A. Kues, Absorption and fluorescence properties of cyanine dyes. J. Chem. Engin. Data 22, 379 (1977).
56. R. Philip, A. Penzkofer, W. Baumler, R. M. Szeimies, and C. Abels, Absorption and fluorescence spectroscopic investigation of indocyanine green. J. Photochem. Photobiol. A-Chem. 96, 137 (1996).
57. J. M. Devoisselle, S. Soulie-Begu, S. Mordon, T. Desmettre, and H. Maillols, A preliminary study of the in vivo behaviour of an emulsion formulation of indocyanine green. Lasers Med. Sci. 13, 279 (1998).
58. A. P. Ranjan, K. Zeglam, A. Mukerjee, S. Thamake, and J. K. Vishwanatha, A sustained release formulation of chitosan modified PLCL: Poloxamer blend nanoparticles loaded with optical agent for animal imaging. Nanotechnol. 22, 9 (2011).
59. C. H. Lee, S. H. Cheng, Y. J. Wang, Y. C. Chen, N. T. Chen, J. Souris, C. T. Chen, C. Y. Mou, C. S. Yang, and L. W. Lo, Nearinfrared mesoporous silica nanoparticles for optical imaging: Characterization and in vivo biodistribution. Adv. Func. Mater. 19, 215 (2009).